B Vitamins + Spinal Manipulation for Low Back Pain
(VCLBP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you've taken B6, B12, or folic acid in the past 15 days.
Is spinal manipulation generally safe for humans?
How does the treatment of B Vitamins + Spinal Manipulation for Low Back Pain differ from other treatments?
This treatment is unique because it combines B vitamins, which have been shown to enhance pain relief and reduce the need for NSAIDs (nonsteroidal anti-inflammatory drugs), with spinal manipulation, a physical therapy technique. This dual approach may offer a more comprehensive solution by addressing both nutritional and mechanical aspects of low back pain.678910
What is the purpose of this trial?
The purpose of this investigation is to assess the effects of a combination of B vitamins (B6 \[pyridoxine\],, B9 \[folate\], and B12 \[cyanocobalamin\] upon the efficacy and duration of spinal manipulation in its treatment of chronic low back pain. Outcome measures over a 12-week period include disability (the Oswestry Disability Index), pain (the Quadruple Visual Analog Scale), and quality of life (Short Form 36 Scale). A total of 60 patients are to be recruited by a single practicing chiropractor who will randomize consenting patients into two groups of 30, one of which will take 3 tablets of the Standard Process folic acid B12 and one tablet of Standard Process B6 Niacinamide between 8:30 - 10:30 am each day and the other 4 tablets of placebo fabricated by Standard Process. Both groups will receive treatments from their chiropractor in the manner they would normally experience as patients. Outcomes will be measured 2 weeks prior to commencing the protocol (baseline), at baseline, immediately upon commencing the protocol, and at one, 2, and 3 months following.. Hypotheses are as follows:HO: Differences in the Oswestry Disability Index (primary outcome) between the experimental and placebo groups will not be clinically and statistically significant at 3 months of treatment.HA: Differences in the Oswestry Disability Index (primary outcome) between the experimental and placebo groups will be clinically and statistically significant at 3 months of treatment.Secondary outcomes will be evaluated in the same manner.
Eligibility Criteria
This trial is for individuals experiencing chronic low back pain. Participants must be willing to undergo spinal manipulation therapy and take B vitamin supplements or a placebo daily. Specific eligibility criteria are not provided, but typically participants would need to meet certain health conditions.Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline questionnaires and are randomized into treatment groups
Treatment
Participants receive chiropractic care and either vitamin or placebo pills for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- B Vitamin Supplementation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Western States
Lead Sponsor